The last 100 years of sepsis

被引：111

作者：

Vincent, JL

Abraham, E

机构：

[1] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium

[2] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA

[3] Hlth Sci Ctr, Denver, CO USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 03期

关键词：

endotoxin; cytokines; epidemiology; septic shock; immunomodulation;

D O I：

10.1164/rccm.200510-1604OE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Over the last 100 years, huge advances have been made in the field of sepsis in terms of pathophysiology, epidemiology, diagnosis, monitoring, and therapeutics. Here, we offer our perspective of the key changes and current situation in each of these areas. Despite these changes, mortality rates remain unacceptably high and continued progress, particularly in early diagnosis and therapy, is urgently needed.

引用

页码：256 / 263

页数：8

共 117 条

[1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[2] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].

Abraham, E ;

Laterre, P ;

Garg, R ;

Levy, H ;

Talwar, D ;

Trzaskoma, BL ;

Francois, B ;

Guy, JS ;

Bruckmann, M ;

Rea-Neto, A ;

Rossaint, R ;

Perrotin, D ;

Sablotzki, A ;

Arkins, N ;

Utterback, BG ;

Macias, WL .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341

[3]

AGRAHAM E, 1984, CRIT CARE MED, V12, P664

[4] Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients [J].

Alberti, C ;

Brun-Buisson, C ;

Goodman, SV ;

Guidici, D ;

Granton, J ;

Moreno, R ;

Smithies, M ;

Thomas, O ;

Artigas, A ;

Le Gall, JR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (01) :77-84

[5] CIRCULATION AND RESPIRATION DURING AN EPISODE OF CHILL AND FEVER IN MAN [J].

ALTSCHULE, MD ;

FREEDBERG, AS ;

MCMANUS, MJ .

JOURNAL OF CLINICAL INVESTIGATION, 1945, 24 (06) :878-889

[6] Coagulation in sepsis [J].

Amaral, A ;

Opal, SM ;

Vincent, JL .

INTENSIVE CARE MEDICINE, 2004, 30 (06) :1032-1040

[7] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].

Angus, DC ;

Linde-Zwirble, WT ;

Lidicker, J ;

Clermont, G ;

Carcillo, J ;

Pinsky, MR .

CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310

[8] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].

Annane, D ;

Sébille, V ;

Charpentier, C ;

Bollaert, PE ;

François, B ;

Korach, JM ;

Capellier, G ;

Cohen, Y ;

Azoulay, E ;

Troché, G ;

Chaumet-Riffaut, P ;

Bellissant, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871

[9] Association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock [J].

Appoloni, O ;

Dupont, E ;

Vandercruys, M ;

Andriens, M ;

Duchateau, J ;

Vincent, JL .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (06) :486-488

[10] Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome [J].

Bates, DW ;

Parsonnet, J ;

Ketchum, PA ;

Miller, EB ;

Novitsky, TJ ;

Sands, K ;

Hibberd, PL ;

Graman, PS ;

Lanken, PN ;

Schwartz, JS ;

Kahn, K ;

Snydman, DR ;

Moore, R ;

Black, E ;

Platt, R .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) :582-591

← 1 2 3 4 5 6 7 8 9 10 →